| Cecelia Bing, NP-C | |
|
106 Willowick Dr, Lithonia, GA 30038-1724 | |
| (678) 438-4600 | |
| Not Available |
| Full Name | Cecelia Bing |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 106 Willowick Dr, Lithonia, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265882542 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Cecelia Bing, NP-C 106 Willowick Dr, Lithonia, GA 30038-1724 Ph: (678) 438-4600 | Cecelia Bing, NP-C 106 Willowick Dr, Lithonia, GA 30038-1724 Ph: (678) 438-4600 |
News Archive
A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.
Pharma Two B announced today it is planning a Phase II study of its new combination therapy, P2B001, in development as a treatment for the early stages of Parkinson's disease. Assuming regulatory approval and the necessary financing, the company plans to commence the Phase II trial in Q4 2011.
The vocal lip-smacks that geladas use in friendly encounters have surprising similarities to human speech, according to a study reported in the Cell Press journal Current Biology on April 8th.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL147 (SAR245408), a selective, orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K). Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
UCB SA, on behalf of its affiliate UCB Pharma S.A., and PDL BioPharma, today jointly announced that the companies have entered into a definitive settlement agreement that resolves all legal disputes between them, including those relating to UCB's pegylated humanized antibody fragment, Cimzia, and PDL's patents known as the Queen et al. patents.
› Verified 4 days ago
Agnes P Oyewo, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5440 Hillandale Drive, Kaiser Permanente Panola Medical Office, Lithonia, GA 30058 Phone: 770-322-2777 Fax: 678-610-6025 | |
Ms. Tonecesa Burtton, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6231 Waterton Way, Lithonia, GA 30058 Phone: 770-462-9202 | |
Ms. Abisola A Ajayi, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5700 Hillandale Dr, Suite 250, Lithonia, GA 30058 Phone: 770-981-5431 Fax: 770-981-5515 | |
Lenice Murdock-cohen, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3641 Raiders Ridge Dr, Lithonia, GA 30038 Phone: 404-444-0649 | |
Glory Abuajah, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2801 Dekalb Medical Pkwy, Lithonia, GA 30058 Phone: 404-501-8460 | |
Mr. Simon Njelefack Ekokobe, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1487 Alice Ave, Lithonia, GA 30058 Phone: 404-314-0776 | |
Mrs. Lisa Marie Rose-cantrell, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5440 Hillandale Drive, Kaiser Permanente Panola Medical Center, Lithonia, GA 30058 Phone: 770-322-3216 Fax: 770-938-1759 |